Cargando…

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy

BACKGROUND: The clinical values of inflammatory and nutritional markers remained unclear for gastric cancer with neoadjuvant chemotherapy (NACT). METHODS: The inflammatory, nutritional markers and their changes were analyzed for locally advanced gastric cancer with NACT. The predictive value was eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ziyu, Li, Shuangxi, Ying, Xiangji, Zhang, Lianhai, Shan, Fei, Jia, Yongning, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165147/ https://www.ncbi.nlm.nih.gov/pubmed/32072387 http://dx.doi.org/10.1007/s10120-019-01027-6

Ejemplares similares

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
por: Liu, Zining, et al.
Publicado: (2021)

Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial
por: Li, Ziyu, et al.
Publicado: (2018)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis
por: Li, Ziyu, et al.
Publicado: (2018)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
por: Liu, Zining, et al.
Publicado: (2021)

Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
por: Li, Bailong, et al.
Publicado: (2023)

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients
por: Li, Ziyu, et al.
Publicado: (2016)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer
por: Wu, Zhouqiao, et al.
Publicado: (2021)

Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: a retrospective cohort study
por: Wang, Yinkui, et al.
Publicado: (2022)

Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial
por: Li, Ziyu, et al.
Publicado: (2018)

Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study
por: Li, Ziyu, et al.
Publicado: (2015)

Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials
por: Lei, Xiaokang, et al.
Publicado: (2022)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma
por: Li, Ziyu, et al.
Publicado: (2020)

Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study
por: Li, Ziyu, et al.
Publicado: (2020)

Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis
por: Li, Ziyu, et al.
Publicado: (2017)

D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
por: Shrikhande, Shailesh V, et al.
Publicado: (2013)

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection
por: Wang, Xiaohong, et al.
Publicado: (2017)

Global burden prediction of gastric cancer during demographic transition from 2020 to 2040
por: Yan, Chao, et al.
Publicado: (2023)

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)

Correction: Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2014)

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
por: Park, Jin-Soo, et al.
Publicado: (2021)

Clinical predictive efficacy of C-reactive protein for diagnosing infectious complications after gastric surgery
por: Shi, Jinyao, et al.
Publicado: (2020)

Could the Extent of Lymphadenectomy Be Modified by Neoadjuvant Chemotherapy in Cervical Cancer? A Large-Scale Retrospective Study
por: Hu, Ting, et al.
Publicado: (2015)

A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients
por: Zheng, Zhixue, et al.
Publicado: (2016)

Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues
por: Marano, Luigi, et al.
Publicado: (2023)

Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China
por: Ji, Jiafu, et al.
Publicado: (2021)

Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis
por: Guan, Guangmin, et al.
Publicado: (2022)

Comparing extended and standard lymphadenectomy surgeries for bladder cancer (complications, final outcomes and effects of neoadjuvant chemotherapy)
por: Thiara, GS, et al.
Publicado: (2015)

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
por: Zhang, Lianhai, et al.
Publicado: (2013)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

Impact of postoperative major complications on long-term survival after radical resection of gastric cancer
por: Yuan, Peng, et al.
Publicado: (2019)

Early diagnosis of anastomotic leakage after colorectal cancer surgery using an inflammatory factors-based score system
por: Shi, Jinyao, et al.
Publicado: (2022)

Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
por: He, Minjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umrthnt53d7hmevgt6l4jlge0f